TXNL1 and myocardial ischemia: TXL may diminish hypoxia/reoxygenation-induced cardiomyocyte damage (Chen et al., 2017), through activation of nitric synthase, mitigate myocardial ischemia/reperfusion injury (Chen et al., 2020), and stimulate rat crown angiogenesis after permanent ligation of the coronary artery (Li et al., 2017).